The Limulus amebocyte lysate assay is a rapid diagnostic test used for the detection of:
**Core Concept**
The Limulus amebocyte lysate (LAL) assay is a biological test based on the coagulation cascade of the horseshoe crab's blood. It leverages the innate immune response of the Limulus polyphemus, which responds to bacterial endotoxins by activating a coagulation pathway.
**Why the Correct Answer is Right**
The LAL assay detects gram-negative bacterial endotoxins, specifically lipopolysaccharides (LPS), by triggering the coagulation cascade in horseshoe crab amebocytes. This results in the formation of a gel-like clot, indicating the presence of endotoxins. The LAL assay is widely used in the pharmaceutical industry to detect endotoxins in parenteral products, such as vaccines, injectables, and implants.
**Why Each Wrong Option is Incorrect**
* **Option A:** The LAL assay is not typically used for the detection of viral infections or prions. The test is specific to gram-negative bacterial endotoxins.
* **Option B:** While the LAL assay is a rapid diagnostic test, it is not used for detecting fungal infections or toxins. Its specificity is limited to bacterial endotoxins.
**Clinical Pearl / High-Yield Fact**
The LAL assay is a classic example of a biological assay that relies on the unique properties of the horseshoe crab's innate immune response. This assay has been widely adopted in the pharmaceutical industry due to its high sensitivity and specificity for detecting gram-negative bacterial endotoxins.
**Correct Answer: C. Bacterial endotoxins.**